Beyer Pat has filed 20 insider transactions across 2 companies since June 2023.
Most recent transaction: a grant/award of 28145 shares of CONMED Corp ($CNMD) on April 01, 2026.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | CONMED Corp | $CNMD | Beyer Pat | President & CEO | A | RSUs (Restricted Stock Units) | 28145 | $0.00 | 28,145.0000 | 31,149,000 | 9999.99% | 0.09% |
| March 2, 2026 | CONMED Corp | $CNMD | Beyer Pat | President & CEO | A | Options To Purchase Common Stock | 68258 | $0.00 | 68,258.0000 | 31,149,000 | 9999.99% | 0.22% |
| March 2, 2026 | CONMED Corp | $CNMD | Beyer Pat | President & CEO | A | RSUs (Restricted Stock Units) | 28800 | $0.00 | 28,800.0000 | 31,149,000 | 9999.99% | 0.09% |
| June 2, 2025 | Bioventus Inc. | $BVS | Beyer Pat | Director | M | Class A Common Stock | 26493 | $0.00 | 76,436.0000 | 64,547,474 | 53.05% | 0.04% |
| June 2, 2025 | Bioventus Inc. | $BVS | Beyer Pat | Director | M | Restricted Stock Units | 26493 | $0.00 | 0.0000 | 64,547,474 | 100.00% | 0.04% |
| June 3, 2025 | Bioventus Inc. | $BVS | Beyer Pat | Director | A | Restricted Stock Units | 32282 | $0.00 | 32,282.0000 | 64,547,474 | 9999.99% | 0.05% |
| Jan. 2, 2025 | CONMED Corp | $CNMD | Beyer Pat | President & CEO | A | Options To Purchase Common Stock | 86355 | $0.00 | 86,355.0000 | 31,150,000 | 9999.99% | 0.28% |
| June 16, 2024 | Bioventus Inc. | $BVS | Beyer Pat | Director | M | Restricted Stock Units | 965 | $0.00 | 0.0000 | 62,647,554 | 100.00% | 0.00% |
| June 16, 2024 | Bioventus Inc. | $BVS | Beyer Pat | Director | M | Class A Common Stock | 965 | $0.00 | 49,943.0000 | 62,647,554 | 1.97% | 0.00% |
| June 11, 2024 | Bioventus Inc. | $BVS | Beyer Pat | Director | A | Restricted Stock Units | 26493 | $0.00 | 26,493.0000 | 62,647,554 | 9999.99% | 0.04% |
| June 7, 2024 | Bioventus Inc. | $BVS | Beyer Pat | Director | M | Class A Common Stock | 30400 | $0.00 | 48,978.0000 | 62,647,554 | 163.63% | 0.05% |
| June 7, 2024 | Bioventus Inc. | $BVS | Beyer Pat | Director | M | Restricted Stock Units | 30400 | $0.00 | 0.0000 | 62,647,554 | 100.00% | 0.05% |
| April 30, 2024 | CONMED Corp | $CNMD | Beyer Pat | Chief Operating Officer | P | Common Stock | 3000 | $68.30 | 10,807.0000 | 31,548,000 | 38.43% | 0.01% |
| April 24, 2024 | CONMED Corp | $CNMD | Beyer Pat | Chief Operating Officer | A | Options To Purchase Common Stock | 20060 | $70.01 | 20,060.0000 | 31,548,000 | 9999.99% | 0.06% |
| March 1, 2024 | CONMED Corp | $CNMD | Beyer Pat | President Int'l & Global Ortho | A | Options To Purchase Common Stock | 44677 | $0.00 | 44,677.0000 | 31,548,000 | 9999.99% | 0.14% |
| June 16, 2023 | Bioventus Inc. | $BVS | Beyer Pat | Director | M | Class A Common Stock | 965 | $0.00 | 18,578.0000 | 61,389,107 | 5.48% | 0.00% |
| June 16, 2023 | Bioventus Inc. | $BVS | Beyer Pat | Director | M | Restricted Stock Units | 965 | $0.00 | 965.0000 | 61,389,107 | 50.00% | 0.00% |
| June 7, 2023 | Bioventus Inc. | $BVS | Beyer Pat | Director | A | Restricted Stock Units | 30400 | $0.00 | 30,400.0000 | 61,389,107 | 9999.99% | 0.05% |
| June 6, 2023 | Bioventus Inc. | $BVS | Beyer Pat | Director | M | Restricted Stock Units | 16648 | $0.00 | 0.0000 | 61,389,107 | 100.00% | 0.03% |
| June 6, 2023 | Bioventus Inc. | $BVS | Beyer Pat | Director | M | Class A Common Stock | 16648 | $0.00 | 17,613.0000 | 61,389,107 | 1725.18% | 0.03% |